Sunday, July 16, 2023 2:13:06 PM
I think what i was trying to get at was whether BDTX-1535 will demonstrate any effectiveness against
exon 20 insertion or T790M mutations.
If i'm reading the clinical site and BDTX presentation correctly exon 20 and T790M are omitted from the NSCLC trial, however are not omitted from the GBM part.
Osimertinib appears to be ineffective on both mutations which are known to be resistant to TKIs.
https://pubmed.ncbi.nlm.nih.gov/36994936/
Other refs:
https://classic.clinicaltrials.gov/ct2/show/NCT05256290
https://investors.blackdiamondtherapeutics.com/static-files/e5782d24-154c-4d23-af99-a5c3b3b3f9e1
Recent BDTX News
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/13/2024 11:09:49 PM
- Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 11:13:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:10:51 AM
- Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- Black Diamond Therapeutics Announces Changes to Board of Directors • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
- Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting • GlobeNewswire Inc. • 04/07/2024 10:00:00 PM
- Black Diamond Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 03/11/2024 05:14:39 PM
- Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024 • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:45:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:36:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:35:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/15/2024 10:34:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:04:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:07:08 PM
- Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones • GlobeNewswire Inc. • 01/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 12:08:08 PM
- Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM • GlobeNewswire Inc. • 12/13/2023 12:00:00 PM
- Black Diamond Therapeutics to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/07/2023 01:00:00 PM
- Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/06/2023 12:45:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 12:14:57 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM